Tom De Potter
@tomdepotter
Cardiac EP @OLVZaalst @CardioAalst | EHRA Advanced AF course director | EHRA Selection Committee co-chair
ID: 35679291
27-04-2009 05:23:08
482 Tweet
2,2K Followers
596 Following
EHRAPresident Kevin Vernooy (one of the) million dollar question :-) Probably an OAC-treated patient is not the same in terms of risk as an OAC-naïve patient. Certainly not using crude risk assessment such as CHADS-VA. Note In the DOAC trials this percentage (OAC naïve) was much higher-close to 50%